Highlights and Quick Summary
- Gross Margin for the quarter ending December 31, 2022 was 100.0% (a Infinity% increase compared to previous quarter)
- Year-over-year quarterly Gross Margin decreased by 0.0%
- Annual Gross Margin for 2022 was 87.67% (a -119.51% decrease from previous year)
- Annual Gross Margin for 2022 was -449.32% (a 314.23% increase from previous year)
- Annual Gross Margin for 2021 was -108.47% (a -86.89% decrease from previous year)
- Twelve month Gross Margin ending December 31, 2022 was -45.98% (a -Infinity% decrease compared to previous quarter)
- Twelve month trailing Gross Margin increased by 24.81% year-over-year
Trailing Gross Margin for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -45.98% | 0.0% | -38.67% | -36.84% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Gross Margin of Benitec Biopharma Limited
Most recent Gross Marginof BNTC including historical data for past 10 years.Interactive Chart of Gross Margin of Benitec Biopharma Limited
Benitec Biopharma Limited Gross Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 100.0% | 0.0% | 0.0% | 100.0% | 87.67% |
| 2021 | 100.0% | 0.0% | 50.0% | -600.0% | -108.47% |
| 2020 | 2000.0% | -143.64% | 233.33% | -67.86% | 281.37% |
| 2019 | – | – | 431.17% | 21.21% | 96.43% |
| 2018 | – | – | – | – | -17.8% |
| 2017 | – | – | – | -48.86% | 52.34% |
| 2016 | – | – | – | 75.87% | -58.41% |
| 2015 | – | – | – | – | 12.76% |
| 2014 | – | – | – | – | -91.94% |
| 2013 | – | – | – | – | -27.17% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology